PCR London Valves 2015, Berlin: A new team, a new venue, exceptional content

August 28, 2015

For the first time in its 6-year history, PCR London Valves, the world's largest Course solely devoted to addressing the rapidly expanding and innovative field of transcatheter therapies for valvular heart disease, will be taking place in Berlin, Germany, from the 20 to 22 of September 2015. Germany has long been in the forefront of research and development in innovative treatments for heart disease and patient care - it is highly fitting that PCR London Valves is taking place here.

Rapid technological developments, newly affirmed methods of team working and case selection have set the stage for a revolution in the management of valvular heart disease. PCR London Valves 2015, led this year by a new team of Course Directors including Jean Fajadet, Michael Haude, Bernard Prendergast, Corrado Tamburino and Stephan Windecker, offers a programme that reflects the complexity of this field while ensuring ample exposure to the latest practical and scientific advances for all participants. The Heart Team remains an important focus as well, with multiple opportunities for Heart Teams to interact, exchange and learn. Complexity will be interwoven with a commitment to a patient-centred approach.

This year's theme is "The evolution of percutaneous valve therapy from TAVI to mitral intervention". PCR London Valves 2015 focuses on all aspects of these interventions: the established alternative to surgery in inoperable and high-risk patients with severe aortic stenosis, the now considered standard therapy for mitral stenosis and pulmonary valve disease and rapidly emerging treatment options in mitral and tricuspid regurgitation.

Live demonstrations, a key feature of the Course, will be taking place with renowned specialists sharing their technical skills and decision-making processes. These will be broadcast from London (St Thomas' Hospital), Berlin (the Vivantes Klinikum Am Urban/im Friedrichshain/DHZB) and Bad Nauheim (Kerckhoff Heart and Thorax Centre).

"Imaging Sunday", combining state-of-the-art lectures and practical workshops dedicated to the critical role of imaging and its fast technological evolution, will take place on September 20th.

Specific programme tracks throughout the 3 days of the Course ensure that each individual practitioner can easily discover the take-home message they need. These include a "Nurses and Technicians" track involving all aspects of the care of patients with valvular heart disease, an "Innovation Track" highlighting the latest technical advances in transcatheter valve therapy, and "Learning Tracks" focused on the essential tips and tricks for each procedure.

A special dedicated supplement of EuroIntervention will be published for PCR London Valves 2015 which will be a reference work and comprehensive review of the Course.

PCR London Valves is an official course of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the PCR Family of innovated educational programmes dedicated to the advancement of patient care worldwide. For further information about any of the sessions at PCR London Valves, the updated programmes can be found at http://www.pcrlondonvalves.com.
Contact: Isabelle Uzielli, Press Coordinator - iuzielli@europcr.com


Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.